SCHEMBL340998

SCHEMBL340998

CC(C)(C=O)CNCCc1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 6/20 0.48
MAPT P10636 3/20 0.48
GAA P10253 1/20 0.48
ATM Q13315 1/20 0.47
TAAR1 Q96RJ0 1/20 0.47
NPC1 O15118 4/20 0.46
RAB9A P51151 4/20 0.46
ALDH1A1 P00352 3/20 0.45
LMNA P02545 2/20 0.45
MEN1 O00255 1/20 0.45
ALOX12 P18054 1/20 0.45
MAPK1 P28482 1/20 0.45
HTT P42858 1/20 0.45
KMT2A Q03164 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
FDPS P14324 1/20 0.44
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA4 P22748 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9936240 0.81 KMT2A (0.50) MAPTGAARAB9ALMNAMEN1
SCHEMBL13036524 0.81 SIGMAR1 (0.55) SIGMAR1MAPTGAAATMTAAR1
SCHEMBL15387232 0.78 SIGMAR1 (0.52) SIGMAR1MAPTGAAATMTAAR1
SCHEMBL27870822 0.77 MEN1 (0.42) SIGMAR1MAPTATMTAAR1NPC1
SCHEMBL19971105 0.74 SIGMAR1 (0.45) SIGMAR1MAPTMEN1MAPK1KMT2A
SCHEMBL340965 0.74 LMNA (0.52) TAAR1ALDH1A1LMNACYP1A2CYP3A4
SCHEMBL283735 0.73 SIGMAR1 (0.81) SIGMAR1MAPTGAAATMTAAR1
SCHEMBL549085 0.73 SIGMAR1 (0.55) SIGMAR1MAPTGAAATMTAAR1
SCHEMBL21028748 0.73 SLC5A1 (0.43) SIGMAR1KMT2ASMN1; SMN2HPGD
SCHEMBL96457 0.72 TAAR1 (0.52) MAPTATMTAAR1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2651876-B1 POLYAMINES HAVING SECONDARY ALIPHATIC AMINO GROUPS SIKA TECH AG (CH) 2017-08-09 EP claimed
US-8877955-B2 Secondary aminosilanes SIKA TECHNOLOGY AG (CH) 2014-11-04 US claimed
US-20130281562-A1 SECONDARY AMINOSILANES SIKA TECHNOLOGY AG (CH) 2013-10-24 US claimed
EP-2651876-A1 POLYAMINES HAVING SECONDARY ALIPHATIC AMINO GROUPS Sika Technology AG (CH) 2013-10-23 EP claimed
US-20130261270-A1 POLYAMINES HAVING SECONDARY ALIPHATIC AMINO GROUPS SIKA TECHNOLOGY AG (CH) 2013-10-03 US claimed
EP-2468759-A1 Secondary Aminosilanes Sika Technology AG (CH) 2012-06-27 EP claimed
WO-2012080265-A1 POLYAMINES HAVING SECONDARY ALIPHATIC AMINO GROUPS SIKA TECHNOLOGY AG (CH) 2012-06-21 WO claimed
EP-2465843-A1 Polyamines with secondary aliphatic amines Sika Technology AG (CH) 2012-06-20 EP claimed
EP-4626995-A1 MOISTURE AND HEAT-CURABLE SEALING COMPOSITION Sika Technology AG (CH) 2025-10-08 EP disclosed
US-12209157-B2 Polyurethane composition having a low content of monomeric diisocyantes SIKA TECHNOLOGY AG (CH) 2025-01-28 US disclosed
EP-3484898-B1 METHOD OF STABILIZING IMINO-FUNCTIONAL SILANE MOMENTIVE PERFORMANCE MAT INC (US) 2023-06-28 EP disclosed
CN-112533972-B Polyurethane compositions with low levels of monomeric diisocyanates SIKA技术股份公司 2023-05-23 CN disclosed
EP-4053134-A1 METHOD OF STABILIZING IMINO-FUNCTIONAL SILANE Momentive Performance Materials Inc. (US) 2022-09-07 EP disclosed
CN-109563111-B Method for stabilizing imino-functional silanes 莫门蒂夫性能材料股份有限公司 2022-04-12 CN disclosed
EP-2236535-A1 Humidity curing polyurethane composition being accelerated by influence of heat Sika Technology AG (CH) 2010-10-06 EP disclosed
EP-2236533-A1 Heat curing or heat activatable composition comprising a surface deactivated polyisocyanate Sika Technology AG (CH) 2010-10-06 EP disclosed
US-20100101455-A1 ALDIMINES AND COMPOSITIONS COMPRISING ALDIMINE SIKA TECHNOLOGY AG (CH) 2010-04-29 US disclosed
EP-2178828-A1 ALDIMINES AND COMPOSITIONS COMPRISING ALDAMINE Sika Technology AG (CH) 2010-04-28 EP disclosed
WO-2009010522-A1 ALDIMINES AND COMPOSITIONS COMPRISING ALDAMINE SIKA TECHNOLOGY AG (CH) 2009-01-22 WO disclosed
EP-2017260-A1 Aldimines and compounds containing aldimine Sika Technology AG (CH) 2009-01-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130281562-A1 SECONDARY AMINOSILANES AS3MT, SRM, MSN SIGMAR1 1574/4885MAPT 2333/4885GAA 1334/4885
US-20100101455-A1 ALDIMINES AND COMPOSITIONS COMPRISING ALDIMINE ALDH7A1, ILK, ALDH3A1 SIGMAR1 4284/4885MAPT 456/4885GAA 873/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.